SAI
NVAX icon

Systematic Alpha Investments’s Novavax NVAX Stock Holding History

Systematic Alpha Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-480
Closed -$71K – 399
2021
Q3 		$71K Hold
480
– – ﹤0.01% 295
2021
Q2 		$111K Buy
+480
New +$87.9K 0.01% 204

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Systematic Alpha Investments's NVAX Position: Q4 2021 in Review

Systematic Alpha Investments sold out of Novavax (NVAX) in Q4 2021, closing a stake of 480 shares — an estimated $71K sold.

Systematic Alpha Investments first reported a position in NVAX in Q2 2021 and held it in 2 quarters. The position peaked at $111K in Q2 2021. 429 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

  • Systematic Alpha Investments reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
  • Systematic Alpha Investments sold 480 Novavax shares in Q4 2021, an estimated $71K.
  • Systematic Alpha Investments first reported a position in Novavax in Q2 2021 and held it in 2 quarters.
  • Systematic Alpha Investments's Novavax position peaked at $111K in Q2 2021.
  • 429 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on Systematic Alpha Investments's 13F filing for Q4 2021, filed 15 Feb 2022.